Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and - Top-Institutions - MDSpire

Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and

  • By

  • Wei Zhang

  • Haowen Wu

  • Langkun Wang

  • Hang Xu

  • Tianhai Lin

  • Ping Tan

  • Peng Zhang

  • Xiaonan Zheng

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mount Sinai Tisch Cancer Center
    Mount Sinai Tisch Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill

    Chapel Hill, NC

    Key Differentiators

    • Oncology

  • #5

    NYU Langone Medical Center
    NYU Langone Medical Center

    New York, NY

    Key Differentiators

    • Oncology

Original Source(s)

Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and

  • by Wei Zhang, Haowen Wu, Langkun Wang, Hang Xu, Tianhai Lin, Ping Tan, Peng Zhang, Xiaonan Zheng

  • June 1, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity